Subscribe To
Clingen to distribute humanigen covid treatment in europe through managed access
Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...
October 8, 2021, 3:29 am
Abbvie's upadacitinib (rinvoq®) met primary and most ranked secondary endpoints in phase 3 study for non-radiographic axial spondyloarthritis
NORTH CHICAGO, Ill., Oct. 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from Study 2 of the Phase 3 SELECT-AX...
October 7, 2021, 8:16 am
Abbvie's upadacitinib (rinvoq®) met primary and most ranked secondary endpoints in phase 3 study for non-radiographic axial spondyloarthritis
NORTH CHICAGO, Ill., Oct. 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from Study 2 of the Phase 3 SELECT-AX...
October 7, 2021, 8:16 am
Abbvie's upadacitinib (rinvoq®) met primary and most ranked secondary endpoints in phase 3 study for non-radiographic axial spondyloarthritis
NORTH CHICAGO, Ill., Oct. 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from Study 2 of the Phase 3 SELECT-AX...
October 7, 2021, 8:16 am